Press Releases

10.17.18
OpGen Announces Proposed Public Offering of Common Stock
10.15.18
OpGen Provides Business and Preliminary Financial Update
09.25.18
OpGen to Present at Two Upcoming Investment Conferences in October
09.24.18
OpGen Partnering with New York State Department of Health and Merck’s ILÚM Health Solutions to Detect Antimicrobial-Resistant Infections
08.29.18
OpGen to Present at the 20th Annual Rodman & Renshaw Global Investment Conference
08.02.18
OpGen Reports Second Quarter 2018 Financial Results And Provides Business Update
07.25.18
OpGen Announces Date of Second Quarter 2018 Financial Results Conference Call
06.14.18
OpGen Modifies Terms of Debt with Merck Global Health Innovation Fund
06.12.18
OpGen Presents Data at ASM Microbe 2018 Demonstrating High Accuracy of Acuitas® for Predicting Antibiotic Resistance in Urine Specimens
06.05.18
OpGen’s Acuitas® AMR Gene Panel u5.47 Data to be Presented at ASM Microbe 2018